NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Keywords:
hepatocyte, steatohepatitis, hepatosis, triglycerides, steatosis, insulin resistance.Abstract
Non-alcoholic fatty liver disease (NAFLD) is a chronic non-infectious disease in which structural changes occur in the liver tissue. The main manifestation of the pathology is excessive deposition of fats (mainly triglycerides) in liver cells - hepatocytes. As the process progresses, inflammation (steatohepatitis), formation of fibrous tissue, and in severe cases - cirrhosis may develop. In everyday life, NAFLD is often called "fatty liver" or fatty hepatosis. Although the disease usually proceeds relatively calmly and without pronounced symptoms, its presence is closely associated with metabolic disorders, which significantly increases the risk of cardiovascular complications. This, in turn, negatively affects the general condition of the patient, reduces the duration and quality of life.
References
Clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association. Hepatology, journal. No. 2, 2016. P. 24-42.
Bueverov A.O., Bogomolov P.O., Maevskaya M.V. Pathogenetic treatment of non-alcoholic steatohepatitis: rationale, efficacy, safety // Therapeutic archive – 2007. – Vol. 79. – No. (8). – P. 1-4.
Lazebnik L.B., Radchenko V.G., Golovanova E.V. et al. Non-alcoholic fatty liver disease: clinical presentation, diagnosis, treatment // Experimental and clinical gastroenterology. - M., 2015. - No. 7. - P. 85-96.
Mantovani A, Csermely A, Bilson J, et al Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis Gut Published Online First: 23 May 2024. doi: 10.1136/gutjnl-2024-332491.
Del Campo JA, Gallego-Durán R, Gallego P, Grande L. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). Int J Mol Sci. 2018 Mar 19;19(3) [PMC free article] [PubMed]
Basaranoglu M, Neuschwander-Tetri BA. Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. Gastroenterol Hepatol (N Y). 2006 Apr;2(4):282-291. [PMC free article] [PubMed]
Lee YH, Cho Y, Lee BW, Park CY, Lee DH, Cha BS, Rhee EJ. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis. Diabetes Metab J 2019 Feb;43(1):31-45. [PMC free article] [PubMed]
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
